Okay, let's tackle this question about G protein-coupled receptors (GPCRs). The user hasn't provided the options, which is a bit tricky, but I'll start by recalling the core concepts related to GPCRs. GPCRs are a large family of transmembrane receptors that play key roles in cellular signaling. They are involved in various physiological processes and are targets for many drugs.

First, the core concept: GPCRs are seven-transmembrane domain receptors that activate heterotrimeric G proteins upon ligand binding. This activation leads to various intracellular signaling pathways, such as the activation of adenylyl cyclase, phospholipase C, or ion channels. They are the largest family of membrane receptors and are involved in sensory perception, neurotransmission, and hormone signaling.

Now, the correct answer should be something that aligns with these functions. Common true statements about GPCRs include their role in activating second messengers like cAMP or IP3/DAG, their use of G proteins (Gq, Gi, Gs, etc.), and their involvement in amplifying signals through G protein activation. They also can activate other pathways like the MAP kinase cascade via β-arrestin.

For the incorrect options, common distractors might include statements about GPCRs being ligand-gated ion channels (they are not; that's a different receptor type), or about them directly activating enzymes without G proteins (they typically use G proteins as intermediaries). Another wrong option could be about GPCRs having only a single transmembrane domain (they have seven). Also, some options might incorrectly state that GPCRs are exclusively inhibitory, but they can be either stimulatory or inhibitory depending on the G protein subtype.

Clinical pearls: GPCRs are the target of about 34% of all FDA-approved drugs. A high-yield fact is that they activate G proteins by promoting GTP exchange on the α subunit, leading to dissociation of the Gα subunit from the βγ complex. Another point is that they are involved in many diseases, and their malfunction can lead to conditions like hypertension, diabetes, and psychiatric disorders.

Putting this all together, the correct answer would be a statement that accurately describes a feature of GPCRs, such as their seven transmembrane domains, activation of G proteins, or their role in signal transduction pathways. The incorrect options would be those that misrepresent their structure, function, or signaling mechanisms.

**Core Concept**
G protein-coupled receptors (GPCRs) are seven-transmembrane domain receptors that activate heterotrimeric G proteins upon ligand binding. They mediate intracellular signaling via Gα, Gβγ subunits, triggering pathways like cAMP production or Ca²⁺ release.

**Why the Correct Answer is Right**
The correct option likely states that GPCRs activate G proteins by promoting GDP-GTP exchange on the α subunit. Ligand binding induces a conformational change in the GPCR, allowing it to act as a guanine nucleotide exchange factor (GEF) for the Gα subunit. This activates the Gα-GTP complex and dissociates it from the βγ subunit, initiating downstream signaling (e.g., adenylyl cyclase activation by Gs or PLC activation by Gq).

**Why Each Wrong Option is Incorrect**
**Option A:**

✓ Correct Answer: C. G proteins act as inhibitory and excitatory because of difference in alpha subunit